Why Reactive Security Is Failing—And What Comes Next 
Monumental LLC Announces ‘Star Trek: Warp’ Collectible Card Game – Now Available to Wishlist on Steam Thales Addresses Inclusivity With Its ‘Voice Payment Card’
A payment innovation that brings autonomy and convenience to visually impaired people Based on its…
PM Factory Netherlands Deploys Mavenir’s Cloud-Native Packet Gateway to Power its MVNO Solution Set
Mavenir’s cloud-native Packet Gateway enables PM Factory to offer voice & data interconnect services over…
BenevolentAI to Present at 41st Annual J.P. Morgan Healthcare Conference
LONDON–(BUSINESS WIRE)–BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it…
ThunderSoft Joins the Amazon SageMaker Ready Program
LAS VEGAS–(BUSINESS WIRE)–ThunderSoft, announced today it has joined the Amazon SageMaker Ready Program. This designation…
Universal Robina Corporation Selects Blue Yonder to Digitally Transform Planning Capabilities
Leading Filipino consumer food and beverage product company to implement Blue Yonder’s Luminate Planning solutions…
RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”…
Viracta Therapeutics Announces Preliminary Dose-Ranging Data from the Phase 1b/2 Trial of Nana-val in Advanced Epstein-Barr Virus-Positive (EBV+) Solid Tumors at the ESMO Immuno-Oncology Congress
Data from first two dose levels of Nana-val in patients with EBV+ recurrent/metastatic nasopharyngeal carcinoma…
Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022
– Durable partial response (PR) and stable disease (SD) achieved in heavily pre-treated non-small cell…
Fully Charged Wuling Motors Sets Sail On Completion of the Restructuring of New Energy Business
HONG KONG, Dec 1, 2022 – (ACN Newswire) – It was recently known to us…
KB Home Announces the Grand Opening of Legacy at Highland, a New-home Community in Clovis, California
Homebuilder offers personalized, new homes in a highly desirable Fresno-area location, affordably priced from the…
Cognigy Achieves AWS Conversational AI Competency Distinction
DÜSSELDORF, Germany & SAN FRANCISCO–(BUSINESS WIRE)–#cognigy—Cognigy announced today that it has achieved the Amazon Web…
AWS and Slalom Expand Next-Generation Strategic Collaboration
Renewed agreement supports global expansion, strengthens Slalom’s collaboration with AWS Professional Services, and positions both…
Revive Therapeutics Ltd. Announces Offering of Up to $5 Million
TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — REVIVE THERAPEUTICS LTD. (CSE: RVV; OTCQB: RVVTF) (“Revive”…
Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022
LOS ANGELES, Nov. 30, 2022 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) — On November 23, 2022,…
Baudax Bio Announces 1-for-40 Reverse Stock Split
MALVERN, Pa., Nov. 30, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company…
Intellia Therapeutics Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage…
Environmental Solutions Group Holdings Limited, Pioneer in Sustainable Circular Economy Solutions, Announces Signing of Definitive Agreement to Combine with Genesis Unicorn Capital Corp. (Nasdaq:GENQ)
Environmental Solutions Group Holdings Limited (“ESG”) and Genesis Unicorn Capital Limited (“GENQ”) Enter into a…
Science 37 to Present at the 5ᵗʰ Annual Evercore ISI HealthCONx Conference
RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2022 (GLOBE NEWSWIRE) — Science 37® Holdings, Inc. (Nasdaq:…
Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia
REDWOOD CITY, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO),…
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2022 Biotech SMID Cap Conference
HAMILTON, Bermuda, Nov. 30, 2022 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today…